STM Journals Peer-reviewed research from Consortium e-Learning Network

3 publications

  • Published Subscription

    Comparative Study of Vaccine for COVID-19 Available in India

    By Chandani Kamble, Sharad Kamble, Shubham Hanfode, Appasab Tanvashi, Prathmesh Kore

    Abstract: The enduring SARS-CoV-2 deadly disease has led to the focused application of resources and scientific knowledge toward the target of developing investigational vaccines to avoid COVID-19. The greatly collaborative global hard work by private industry, governments, and non-governmental organizations has resulted in several SARS-CoV-2 vaccines. In this review, we provide an overview of the description, vaccine characteristic, developers, and action of vaccine, dose & efficacy of vaccines on Covid-19.

    Published in Research and Reviews : A Journal of Immunology · Vol. 11, Issue 3, 2021 · pp. 1–7 Read article

  • Published Subscription

    Covid-19 Associated Mucormycosis: Urgency To Reconsider The Uncontrolled Use Of Prophylactic Drugs

    By Chandani Kamble, Vikas Kamble, Sharad Kamble, Prakash Kamble, Rani Kamble

    Abstract: Mucormycosis, a lethal mycosis, has affected hundreds of COVID-19 sufferers in India. Mucormycosis, previously known as zygomycosis, is due to the diverse fungi that belong to the family "Mucorales." These molds are normally determined in soil, air, and damp partitions and often colonize oral mucosa, nose, paranasal sinuses, and throat. The pathophysiological results of diabetes mixed with the intense inflammatory surge in COVID-19 and steroid remedy weaken a person's immunity …

    Published in Research and Reviews: A Journal of Medicine · Vol. 11, Issue 3, 2021 · pp. 12–17 Read article

  • Published Subscription

    Novel plasma therapy for covid-19: A Perspective

    By Chandani Kamble, Sharad Kamble, Pragati Pandit

    Abstract: Coronavirus disease (COVID-19) is an induced disease caused by the coronavirus-19 that causes acute respiratory syndrome (SARS COVID-19). In the month of December 2019, the first case was recorded in Wuhan, China. No specific medications have yet been approved for their treatment; convalescent plasma therapy is projected to boost the survival rate. Early in the twentieth century, convalescent plasma therapy was developed. Convalescent plasma therapy is widely utilized around the …

    Published in Research and Reviews: Journal of Oncology and Hematology · Vol. 10, Issue 3, 2021 · pp. 30–34 Read article

Support